Home > Prostate Cancer Research > Research News > Memorial Sloan-Kettering Researchers Discover Prostate Cancer Disease Pathways Regulate Each Other
Research News
Memorial Sloan-Kettering Researchers Discover Prostate Cancer Disease Pathways Regulate Each Other
"Prostate cancer is difficult to control once it spreads beyond the initial tumor to other parts of the body. The standard treatment, androgen receptor (AR) therapy, works for a while by blocking receptors for male sex hormones that are known to fuel prostate tumor growth. But the disease usually becomes resistant and progresses."
Dr. Carver is a PCF Young Investigator and a PCF Challenge Award Co-Investigator. Read about his awards here.
Print |
Stay Informed
Sign up to receive our monthly newsletters.
Research Summaries
News from PCF's annual meeting of prostate cancer researchers.
PCF Guides
Report to the Nation on Prostate Cancer: A Guide for Men and Their Families
Nutrition, Exercise and Prostate Cancer